News articles about Imperva (NYSE:IMPV) have trended somewhat positive this week, Accern Sentiment reports. The research firm identifies negative and positive media coverage by monitoring more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Imperva earned a news impact score of 0.05 on Accern’s scale. Accern also gave media stories about the software maker an impact score of 45.7039046902367 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the immediate future.
Here are some of the news stories that may have effected Accern’s rankings:
- Imperva Inc (IMPV) Expected to Announce Quarterly Sales of $82.29 Million (americanbankingnews.com)
- Imperva Breaks Above 200-Day Moving Average – Bullish for IMPV (marketnewsvideo.com)
- Imperva (IMPV) versus Its Rivals Head to Head Analysis (americanbankingnews.com)
- IMPERVA INCAPSULA PROTECTS NTT TECHNOCROSS CORPORATION AND ITS CUSTOMERS FROMWEBSITEATTACKS (globalbankingandfinance.com)
- $0.24 EPS Expected for Imperva Inc (IMPV) This Quarter (americanbankingnews.com)
Shares of Imperva (NYSE IMPV) traded up 1.85% during midday trading on Friday, hitting $44.10. 1,118,049 shares of the company’s stock traded hands. The firm’s market capitalization is $1.49 billion. The company has a 50 day moving average price of $44.19 and a 200 day moving average price of $45.49. Imperva has a 1-year low of $34.40 and a 1-year high of $57.24.
Imperva (NYSE:IMPV) last announced its earnings results on Thursday, July 27th. The software maker reported ($0.10) earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.05 by ($0.15). Imperva had a negative return on equity of 5.00% and a negative net margin of 4.69%. The company had revenue of $74.44 million during the quarter, compared to the consensus estimate of $74.30 million. During the same period in the prior year, the firm posted ($0.23) earnings per share. The company’s revenue was up 28.6% on a year-over-year basis. Equities analysts anticipate that Imperva will post $0.81 earnings per share for the current year.
A number of brokerages have issued reports on IMPV. UBS AG began coverage on shares of Imperva in a report on Tuesday, June 6th. They issued a “positive” rating and a $60.00 target price on the stock. ValuEngine cut shares of Imperva from a “hold” rating to a “sell” rating in a report on Tuesday, July 11th. Stifel Nicolaus reissued a “hold” rating and issued a $47.00 target price on shares of Imperva in a report on Friday, July 14th. Stephens reissued an “overweight” rating and issued a $61.00 target price (up previously from $53.00) on shares of Imperva in a report on Thursday, July 13th. Finally, BidaskClub raised shares of Imperva from a “sell” rating to a “hold” rating in a report on Tuesday, September 12th. One investment analyst has rated the stock with a sell rating, seven have given a hold rating, thirteen have assigned a buy rating and one has given a strong buy rating to the stock. The stock has an average rating of “Buy” and an average price target of $52.97.
COPYRIGHT VIOLATION NOTICE: This piece of content was first reported by Transcript Daily and is owned by of Transcript Daily. If you are reading this piece of content on another publication, it was stolen and reposted in violation of US and international trademark and copyright legislation. The correct version of this piece of content can be viewed at https://transcriptdaily.com/2017/09/17/imperva-impv-receives-media-impact-rating-of-0-05.html.
In other Imperva news, Director Anthony J. Bettencourt sold 99,598 shares of the business’s stock in a transaction dated Thursday, August 24th. The shares were sold at an average price of $43.59, for a total value of $4,341,476.82. Following the completion of the transaction, the director now directly owns 99,598 shares of the company’s stock, valued at $4,341,476.82. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Insiders own 2.20% of the company’s stock.
Imperva Company Profile
Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services.
Receive News & Ratings for Imperva Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva Inc and related companies with MarketBeat.com's FREE daily email newsletter.